An Act relative to opioid use disorder treatment and rehabilitation coverage

This bill expands health insurance coverage for opioid use disorder treatment in Massachusetts, specifically ensuring that state employees and Medicaid recipients receive medications like naloxone and buprenorphine without deductibles or prior authorization. It mandates that hospitals and substance use disorder treatment facilities provide at least two doses of opioid antagonists to patients upon discharge to prevent overdose. Additionally, the legislation requires the state to purchase and distribute these medications to hospitals and treatment centers at no cost to the facilities. By removing financial barriers and establishing clear protocols for medication distribution, the bill aims to improve access to critical life-saving treatments for individuals recovering from opioid addiction.